<- Go Home

IDT Australia Limited

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States. and internationally. It offers microbiological and analytical testing, clinical packaging, and pharmacy services. The company also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, it offers mRNA and ADCs. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.

Market Cap

$43.0M

Volume

303.7K

Cash and Equivalents

$504.0K

EBITDA

-$5.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$7.5M

Profit Margin

53.46%

52 Week High

$0.14

52 Week Low

$0.08

Dividend

N/A

Price / Book Value

1.50

Price / Earnings

-6.43

Price / Tangible Book Value

1.50

Enterprise Value

$46.5M

Enterprise Value / EBITDA

-9.07

Operating Income

-$6.1M

Return on Equity

22.75%

Return on Assets

-12.69

Cash and Short Term Investments

$904.0K

Debt

$4.5M

Equity

$23.4M

Revenue

$14.0M

Unlevered FCF

-$7.8M

Sector

Pharmaceuticals

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches